Agenda
Back Home
Panel
Global Supply Chain: Challenges & Opportunities for Suppliers to the Industry
10:37 - 11:37
Hear from the trade experts and executives throughout the global supply chain on current and future trends, challenges, and perspectives.

Moderators

Speakers

Panel
Surviving in a Global Trade System
11:39 - 12:39
Surviving in a Global Trade System: An expansive international trade focused panel that will cover cross border concerns from multi-national companies on issues such as taxes, tariffs, movement of goods and services across borders and trade zones, and labor concerns.

Moderators

  • Chris Greer

    Senior Vice President for Regulatory and External Affairs, Stryk Brands

Speakers

  • Tracy Berry

    Vice President, Tax Compliance, Laudisi Enterprises

  • Chris Gemmell

    Chief Product & Innovation Officer, Greentank Technologies

  • Markus Lindblad

    Head of Legal and External Affairs, Haypp Group

Break
Lunch
12:40 - 13:50
Networking lunch
Keynote
Keynote: A Tale of Two Treaties: The Role of Industry in the Framework Conventions on Tobacco Control and Climate Change, Ben Dessart
14:09 - 14:24
Comparing the Framework Conventions on Tobacco Control and Climate Change followed by an expansive international trade-focused panel that will cover cross border concerns from multi-national companies on issues such as taxes, tariffs, movement of goods and services across borders and trade zones, and labor concerns

Moderators

  • Ben Dessart

    Vice President of External Affairs, Universal Corporation

Panel
Innovative Responses to Climate Change & Global Climate Policy
14:26 - 15:26
Explore the latest trends in climate policy, industry-government partnerships, and the innovative and transformative programs launched by nicotine industry participants.

Moderators

  • Nicole Austin

    Head of Sustainability Stakeholder Engagement , Philip Morris International

Speakers

Break
Break
15:29 - 15:45
Panel
Playing Defense – Brand Protection and its Impact on Harm Reduction and Consumers
09:25 - 10:25
Global professionals from the largest companies deal with brand integrity and protection issues on a daily basis. Copycats do more than violate IP rights: learn how the fight to protect brand integrity is intricately linked to public health goals, nicotine (mis)perception, and the fight for harm reduction.

Moderators

Speakers

  • Michael Horowitz

    Managing Counsel, RAI Services Company

  • Abel Vecino

    Head of Illicit Trade Prevention for Southwest Europe, Philip Morris International

Panel
Troubled Waters: A tale of two approaches across the Tasman Sea - Australia/New Zealand:
10:27 - 11:15
Everywhere you hear about the contrasting approaches from two close neighbors. But the ANZAC experience is more than a thought exercise. GTNF is proud to platform the heads of the two main retailers’ groups in Australia and New Zealand to hear about the real state of play, the contrasts, and the struggles ahead.

Moderators

Speakers

  • Theo Foukkare

    CEO , Australian Association of Convenience Stores

  • David Hooker

    Executive Director , New Zealand Association of Convenience Stores

Break
Break
11:17 - 11:30
Keynote
Keynote: Eve Wang The Ultra Marathon – Innovation in Science, Tech, and Products:
11:32 - 11:45
Every conference you attend talks about ‘innovation’ and frankly we often find it to be a cliché. At GTNF we’re doing something about that. Innovation is a marathon fueled not by health bars but by Moore’s law. It is a natural source of tension generated by the yawning gap between policy and natural tech evolution. GTNF takes you through a consequential look at innovation. Covering everything from product stewardship advances, product development, utilization of data, to AI; GTNF covers it all.

Moderators

  • Eve Wang

    Executive Director , Smoore International

Panel
Innovation 360: Established Industry
11:47 - 12:47
Three panels with three different perspectives on the impacts, challenges, and opportunities of innovation. Hear from different segments of the tobacco and nicotine industry on not only the latest in innovation – but the ‘what,’ ‘how,’ and ‘why’ of innovation. What are the key challenges and opportunities present in today’s market and what forces outside of product development, science & R&D are impacting what, where, and how industry undertakes innovation. How product science and stewardship advances will change products and consumer preferences. Why change is not only inevitable but necessary.

Speakers

  • Clio Boura

    Head of Science Operations, British American Tobacco

  • Yu Kang

    Head of Research Institute, Hangsen International

Break
Lunch
12:50 - 14:00
Panel
Innovation 360: Up & Comers
14:19 - 15:09
Three panels with three different perspectives on the impacts, challenges, and opportunities of innovation. Hear from different segments of the tobacco and nicotine industry on not only the latest in innovation – but the ‘what,’ ‘how,’ and ‘why’ of innovation. What are the key challenges and opportunities present in today’s market and what forces outside of product development, science & R&D are impacting what, where, and how industry undertakes innovation. How product science and stewardship advances will change products and consumer preferences. Why change is not only inevitable but necessary.

Moderators

  • Dr. Anna Franzén

    Chief Regulatory, Clinical & Quality Officer, Emplicure Consumer AB

Speakers

Break
Break
15:10 - 15:20
Panel
Clinician’s Summit
09:10 - 10:10
An in-depth exploration of risk and harm reduction from practicing clinicians that covers comparative and contrasting approaches amongst multiple issues from obesity, diet, illicit drugs, alcohol, and tobacco use.

Speakers

  • Dr. Jasjit Ahluwalia

    Professor of Behavioral and Social Sciences and Professor of Medicine, Brown University School of Public Health and Alpert School of Medicine

  • Garrett McGovern

    Medical Director, Priority Medical Clinic

  • Dr. Riccardo Polosa

    Founder, Center of Excellence for the Acceleration of Harm Reduction

Break
Break
10:28 - 10:43
Panel
TPD: Science Behind Legislation to Reduce Harm
10:45 - 11:45
TPD3 is one of the biggest headlines in tobacco and nicotine policy. Behind the punditry and headlines and clickable content is the important work of imperial evidence supporting regulations. This panel will examine the state of science and evidence and its impact on TPD3.

Moderators

Speakers

Keynote
The Forgotten Smoker
11:47 - 12:02

Moderators

  • Joe Williams

    Senior Manager, Regulatory Engagement, Altria Client Services, Altria Client Services

Speakers

  • Dave Dobbins

    Principal Consultant, Dobbins Consulting

  • Brian Erkkila

    Director, External Affairs & Head of Scientific Engagement, PMI

Break
Lunch
12:03 - 13:15
Panel
New Approaches to Harm Reduction
13:17 - 14:17
THR is awash in variables - dispirited populations, geographies, and cultures combined with the fact that harm reduction is multi-faceted and encompasses everything from social and environmental impacts to individual and population health - and this diversity cannot be managed as a global one-size-fits-all solution. From unintended consequences to outright frustration of public health goals, failing to adapt, learn and change approaches to THR has real consequences. This panel explores new approaches around the globe that are making progress, providing learning opportunities of adoption elsewhere, or are efforts worthy of a global stage.

Moderators

  • Mohamadi Sarkar

    Fellow of Scientific Strategy and Analysis and Regulatory Affairs, Altria Client Services

Speakers

Panel
The Ban Wagon Effect: Do Bans Work
14:19 - 15:19
Product category, flavor, birthdates – are bans effective or simply creating new problems. Does legislating a ban get rid of a problem? Bans are being proposed around the world in innovative and traditional forms: phased illegalization based on date of birth, constriction of product attributes and sales channels, and, of course, outright prohibitions. Measures are gaining traction from one geography to another. But if we dive deeper, what is a ban, and what does it actually do? Bans are simple and easy to package to constituents: "Because of X, we are banning Y." Simple messaging often belies more complexity in an issue hiding below the surface. This panel explores that complexity from why bans come about, what's standardized and what's unique to them, and, most importantly, to their highly complex effects: incentivization of illicit markets to satisfy demand; economic impacts from resource diversion for enforcement to losses throughout the value chain; and frustration of overarching THR and wider public health goals tied to consumer demand shifts to illicit products, backsliding to less harm-reduced ones, and social costs of the "illicitization" of products.

Moderators

  • Dr. Jessica Zdinak

    Founder and Chief Research Officer, Applied Research and Analysis Company

Speakers